aclaristx.com (ACRS) Company Sales Volume

Corporate emblem and logo of Aclaris Therapeutics, Inc. (ACRS)

Risks for Aclaris Therapeutics (ACRS) are linked to a dependence on FDA approvals and the lack of a broad customer base. However, robotic molecule screening accelerates drug discovery, while exclusive patents enable the company to maintain significant pricing power. The company's sales volume reflects a sales trend where the 0.01 level serves as a critical support mark, helping to assess the business's ability to act as a cash generator.

ACRS Aclaris: Revenue and Sales Volume in the range 07/04/2022 - 11/17/2026

Analytical breakdowns for Aclaris Therapeutics

- price and consensus price forecast:
Summary company analysis:ACRS, aclaristx.com
Signature product of Aclaris Therapeutics Inc.

This indicator aggregates daily cash inflows from product sales, measuring the actual liquidity of operating activities. The metric allows for the filtering of market noise, confirming the business's fundamental resilience to losses. For Aclaris Therapeutics (ACRS), revenue growth depends directly on drug commercialization and the success of clinical phases. Patent protection of molecules determines the long-term stability of flows. By analyzing the company's financial sales results, an investor assesses real market demand.

Analysis of competing companies

Revenue and Sales Volume argenx.com|Company Revenue BioNTech Group (BNTX)|Abivax S.A. - Company Sales Volume|Revenue and Sales Volume ADMA (admabiologics.com)|Protagonist Corp (PTGX) - Company Total Revenue|immunovant.com - Revenue and Sales Volume|KNSA - Revenue and Sales Volume|Grifols (GRFS) - Company Revenue|Company Sales Volume ADPT|Company Revenue Celldex|AUPH: Company Sales Revenue|Revenue and Sales Volume BCRX|Revenue and Sales Volume Vera Therapeutics (VERA)|Dianthus Therapeutics - Company Sales|Pharvaris - Company Revenue|ABCL - Company Revenue|TRML - Revenue and Sales Volume|PGEN: Revenue and Sales Volume|Company Sales Volume PHAR|Company Sales NKTR|UPB: Company Sales Revenue|Company Revenue zenasbio.com (ZBIO)|IMNM (Immunome Corp) - Company Sales Revenue|Revenue and Sales Volume GOSS (Gossamer Bio, Inc.)|KALV (KalVista Pharmaceuticals) - Company Annual Revenue|SEPN - Company Revenue|Company Sales Revenue PVLA (Pieris Pharma)|Savara Pharma (SVRA) - Company Revenue|Rigel Pharmaceuticals Inc (RIGL) - Revenue and Sales Volume|Company Revenue AnaptysBio|Astria Therapeutics - Company Annual Revenue|Revenue and Sales Volume ENGN|Company Total Sales RAPT|Company Revenue Aerovate Therapeutics, Inc. JBIO|Kyverna Therapeutics (KYTX) - Company Total Revenue|tizianalifesciences.com - Revenue and Sales Volume|CABA (Cabaletta Bio, Inc.) - Company Sales Volume|VTYX: Revenue and Sales Volume|THTX - Company Gross Revenue|Company Revenue Avalo Therapeutics Inc|Eledon (ELDN) - Company Gross Revenue|Company Revenue agenusbio.com (AGEN)|CLYM (Climb Bio Inc) - Company Sales Revenue|Revenue and Sales Volume ZURA (zurabio.com)|Company Sales Revenue ATYR|ADAG - Company Revenue|ikenaoncology.com (IMA) - Company Sales|Shattuck Labs (STTK) - Company Revenue|EQ - Company Gross Revenue|CNTB (connectbiopharm.com) - Revenue and Sales Volume|IMUX: Company Sales Revenue|Company Revenue Atara Biotherapeutics, Inc. (ATRA)|Company Gross Revenue InflaRx NV|Revenue and Sales Volume XFOR (X4 Pharmaceuticals)|Revenue and Sales Volume Adicet Bio ACET|CELU: Company Sales|Company Sales Revenue INMB (INmune Bio)|Barinthus Bio (BRNS) - Company Revenue|Kezar Life Sciences (KZR) - Revenue and Sales Volume|Company Revenue sabbiotherapeutics.com|Revenue and Sales Volume Akari Therapeutics Plc|Company Revenue Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp (QTTB) - Company Total Sales Volume|Company Revenue GeoVax Corp GOVX|Company Gross Revenue Edesa Biotech Corp (EDSA)|IBIO: Company Sales|Company Sales Revenue CARM (carismatx.com)|XTLB: Revenue and Sales Volume|BOLT - Company Gross Revenue|Company Sales HCWB|Company Sales Aptevo Therapeutics Inc. (APVO)|Revenue and Sales Volume AIM|ADTX: Company Annual Revenue|GRI Bio - Company Sales|Company Gross Revenue XORTX Therapeutics Inc (XRTX)|HIND: Company Sales|Revelation Biosciences (REVB) - Company Sales|Indaptus Therapeutics, Inc. (INDP) - Company Revenue|SCNI - Company Gross Revenue|CALI (CalciMedica) - Revenue and Sales Volume|Revenue and Sales Volume affimed.com|Company Revenue Allakos Therapeutics (ALLK)|HOOK - Company Total Revenue|Company Revenue IGM Biosciences, Inc. IGMS|Company Gross Revenue iTeos Therapeutics, Inc. (ITOS)|Ocean Biomedical Corp - Revenue and Sales Volume|TC BioPharm (TCBP) - Company Sales|THRD: Revenue and Sales Volume